Chromosomal Deletions in Myelodysplasia

References

• Bennet J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D. A. G., Gralnick H.R., Sultan C. The French-American-British (FAB) Cooperative Group: Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Mufti G.J. Chromosomal deletions in the myelodysplastic syndrome. Leulc Res. 1992; 16: 35–41
   PubMed Web of Science ®Google Scholar
• Johansson B., Martens F., Mitelman F. Cytogenetic deletion maps of hematologic neoplasms. Genes, Chromosomes and Cancer 1993; 8: 205–218
   PubMed Web of Science ®Google Scholar
• Le Beau M.M., Albain K.S., Larson R.A., Vardiman J.W., Davis E.M., Blough R.R., Golomb H.M., Rowley J.D. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute non-lymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes nos. 5 & 7. J. Clin. Oncol. 1986; 4: 325–345
   PubMed Web of Science ®Google Scholar
• Heim S., Mitelman F. Chromosome abnormalities in the myelodysplastic syndromes. Clin. Haematol. 1986; 15: 1003–1021
   PubMedGoogle Scholar
• Huebner K., Nowell P.C., Croce C.M. Lineage-specific gene rearrangement/deletion: a nonconservative model. Cancer Res. 1989; 49: 4071–4074
   PubMed Web of Science ®Google Scholar
• Hirst W.J., Czepulkowski B., Mufti G.J. Consistent interstitial chromosomal deletions in myeloid malignancies and their correlation with fragile sites. Cancer Genet. Cytogenet. 1993; 65: 51–57
   PubMed Web of Science ®Google Scholar
• Marx J. Learning how to suppress cancer. Science 1993; 261: 1385–1387
   PubMed Web of Science ®Google Scholar
• Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S., Hedge P., Markham A., Krush A.J., Petersen G., Hamilton H.R., Nilbert M.C., Levy D.B., Bryan T.M., Preisinger A.C., Smith K.J., Su L.-K., Kinzler K.W., Vogelstein B. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665–669
   PubMed Web of Science ®Google Scholar
• Borgstrom G.H., Teerenhovi L., Vuopio P., de la Chapelle A., Van Den Berghe H., Brandt L., Golomb H.M., Louwagie A., Mitelman F., Rowley J.D., Sandberg A.A. Clinical implications of monosomy 7 in acute nonlymphocytic leukemia. Cancer Genet. Cytogenet 1980; 2: 115–126
   Web of Science ®Google Scholar
• Ruutu P., Ruutu T., Vuopio P., Kosunen T.U., de la Chapelle A. Defective chemotaxis in monosomy 7. Nature 1977; 265: 146
   PubMed Web of Science ®Google Scholar
• Forth International Workshop on Chromosomes in Leukemia. Cancer Genet. Cytogenet. 1984; 11: 296–300, 1982
   PubMedGoogle Scholar
• Kere J., Donis K.H., Ruutu T., de la Chapelle A. Chromosome 7 long-arm deletions in myeloid disorders: terminal DNA sequences are commonly conserved and breakpoints vary. Cytogenet. Cell Genet. 1989; 50: 226–229
   PubMedGoogle Scholar
• Lewis S., Abrahamson G.M., Boultwood J., Fidler C., Potter A., Wainscoat J.S. Molecular characterication of the 7q deletion in myeloid disorders, (submitted)
   Google Scholar
• Kere J., Ruutu T., Davies K.A., Roninson I.B., Watkins P.C., Winqvist R., de la Chapelle A. Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined by molecular mapping. Blood 1989; 73: 230–234
   PubMed Web of Science ®Google Scholar
• Powell J.S., Berkner K.L., Lebo R.V., Adamson J.W. Human erythropoietin genes: High level of expression in stably transfected mammalian cells and chromosome localization. Proc. Natl head. Sci. USA. 1986; 83: 6465–6469
   PubMed Web of Science ®Google Scholar
• Kere J. Chromosome 7 long arm deletion breakpoints in preleukemia: mapping by pulsed field gel electrophoresis. Nucleic Acids Res. 1989; 17: 1511–1520
   PubMed Web of Science ®Google Scholar
• Horiike S., Taniwaki M., Misawa S., Abe T. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer 1988; 62: 1129–1138
   PubMed Web of Science ®Google Scholar
• Yunis J.J., Rydell R.E., Oken M.M., Arnesen M.A., Mayer M.G., Lobell M. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 1986; 6: 1721–1730
   Google Scholar
• Dean M., Park M., Le Beau M.M. The human met oncogene is related to the tyrosine kinase oncogenes. Nature 1985; 318: 385–388
   PubMed Web of Science ®Google Scholar
• Kere J., Ruutu T., de la Chapelle A. Monosomy 7 in granulocytes and monocytes in myelodysplastic syndrome. N. Engl. J. Med 1987; 316: 499–503
   PubMed Web of Science ®Google Scholar
• Roninson J.B., Chin J.E., Kyunghee C., Gros P., Housman D.E., Fojo A., Shen D.W., Gottesman M.M., Pastan I. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. USA. 1986; 83: 4538–4542
   PubMed Web of Science ®Google Scholar
• Skalnik D.G., Strauss E.C., Orkin S.H. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox promotor. J. Biol. Chem. 1991; 266: 16736–16744
   PubMed Web of Science ®Google Scholar
• Scherer S.W., Neufeld E.J., Lievens P. M. J., Orkin S.H., Kim J., Tsui L.C. Regional localization of the CCAAT displacement protein gene (CUTL1). Genomics 1993; 15: 695–696
   PubMed Web of Science ®Google Scholar
• Roger-Pokora B., Kunkel L.M., Monaco A.P., Goff S.C., Neqburger P.E., Baehner R.L., Cole F.S., Curnutte J.T., Orkin S.H. Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of chromosomal location. Nature 1986; 322: 32–38
   PubMed Web of Science ®Google Scholar
• Van den Berghe H., Vermaelen K., Mecucci C., Barbieri D., Tricot G. The 5q-anomaly. Cancer Genet. Cytogenet. 1985; 17: 189–255
   PubMed Web of Science ®Google Scholar
• Van den Berghe H., Cassiman J.J., David G., Fryns J.P., Michaux J.L., Sokal G. Distinct haematological disorder with deletion of the long arm of No. 5 chromosome. Nature 1974; 251: 437–438
   PubMed Web of Science ®Google Scholar
• Sokal G., Michaux J.L., Van den Berghe H., Cordier A., Rodham J., Ferrant A., Moriau M., Bruyere M.D., Sonnet J. A new hematological syndrome with adistinet karyotype: the 5q-chromosome. Blood 1975; 46: 519–520
   PubMed Web of Science ®Google Scholar
• Mitelman F., Manolova Y., Manolova G., Billstrom R., Heims S., Kristofferson U., Mandahl N. Analysis of the 5q marker chromosome in refractory anemia. Hereditas 1986; 105: 49–54
   PubMed Web of Science ®Google Scholar
• Pedersen B., Jensen I.M. Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients. Leukemia 1991; 5: 566–573
   PubMed Web of Science ®Google Scholar
• Yunis J.J., Brunning R.D., Howe R.B., Lobell M. High resolution chromosomes as an independent prognostic indicator in adult acute nonlymphocytic leukemia. N. Eng. J. Med. 1984; 311: 812–818
   PubMed Web of Science ®Google Scholar
• Yunis J.J. New chromosome techniques in the study of human neoplasia. Hum. Path. 1981; 12: 540–549
   PubMed Web of Science ®Google Scholar
• Kerkhof S., Hagemijer A., Leeksma C. H. W., Abels J., den Ottolander J., Somens R., Gerrits W. B. J., Langenhoiyen M. M. A., von den Borne A. E. G., Van Hemel J.O., Geraedts J. P. M. The 5q-chromosome abnormality in haematological disorders. Br. J. Haematol. 1982; 52: 365–381
   PubMed Web of Science ®Google Scholar
• Mitelman F., Levan G. Clustering of aberrations to specific chromosomes in human neoplasms IV: A survey of 1,871 cases. Hereditas 1981; 95: 79–139
   PubMed Web of Science ®Google Scholar
• Le Beau M.M., Espinosa R., Neuman W.L., Stock W., Roulston D., Larson R.A., Keinanen M., Westbrook C.A. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc. Natl. Acad. Sci. USA 1993; 90: 5484–5488
   PubMed Web of Science ®Google Scholar
• Boultwood J., Fidler C., Lewis S., Kelly S., Sheridan H., Littlewood T.J., Buckle V.J., Wainscoat J.S. Molecular Mapping of Uncharacteristically small 5q Deletions in Two Patients with the 5q-syndrome: Delineation of the Critical Region on 5q and Identification of a 5q-Breakpoint. Genomics 1994; 19: 425–432
   PubMed Web of Science ®Google Scholar
• Boultwood J., Fidler C., Lewis S., MacCarthy A., Sheridan H., Kelly S., Oscier D., Buckle V.J., Wainscoat J.S. Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q-chromosome in some patients with the 5q-syndrome. Blood 1993; 82: 2611–2616
   PubMed Web of Science ®Google Scholar
• Nagarajan L., Zavadil J., Claxton D., Lu X., Fairman J., Warrington J., Wasmuth J.J., Chinault A.C., Sever C.E., Slovak M.L., Willman C.L., Deisseroth A.B. Consistent Loss of the D5S89 Locus Mapping Telomeric to the Interleukin Gene Cluster and Centromeric to EGR-1 in Patients With 5q-Chromosome. Blood 1994; 83: 199–208
   PubMed Web of Science ®Google Scholar
• Willman C.L., Sever C.E., Pallavicini M.G., Harada H., Tanaka N., Slovak M.L., Yamamoto H., Harada K., Meeker T.C., List A.F., Taniguchi T. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 1993; 259: 968–971
   PubMed Web of Science ®Google Scholar
• Saltman D.L., Dolganov G.M., Warrington J.A., Wasmuth J.J., Lovett M. A physical map of 15 loci on human chromosome 5q23-q33 by two-color fluorescence in situ hybridization. Genomics 1993; 16: 726–732
   PubMed Web of Science ®Google Scholar
• Le Beau M.M. Deletions of chromosome 5 in malignant myeloid disorders. Cancer Surv. 1992; 15: 143–159
   PubMedGoogle Scholar
• Westbrook C.A., Keinanen M.J. Myeloid malignancies and chromosome 5 deletions. Baillieres Clin. Haematol. 1992; 5: 931–942
   PubMed Web of Science ®Google Scholar
• Nigro J.M., Baker S.J., Preisinger A.C., Jessup J.M., Hostetter R., Cleary K., Bigner S.H., Davidson N., Baylin S., Devilee P., Glover T., Collins F.S., Weston A., Modali R., Harris C.C., Vogelstein B. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989; 342: 705–708
   PubMed Web of Science ®Google Scholar
• Shannon K.M., O'Connell P., Martin G.A., Paderanga D., Olson K., Dinndorf P., McCormick F. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N. Engl. J. Med. 1994; 330: 597–601
   PubMed Web of Science ®Google Scholar
• Biegel J.A., Burk C.D., Barr F.G., Emanuel B.S. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res. 1992; 52: 3391–3395
   PubMed Web of Science ®Google Scholar
• Cogen P.H., Daneshvar L., Metzger A.K., Duyk G., Edwards M.S., Sheffield V.C. Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am. J. Hum. Genet. 1992; 50: 584–589
   PubMed Web of Science ®Google Scholar
• Westbrook C.A., Neuman W.L., McPherson J., Camper S., Wasmuth J., Plaetke R., Williamson R. Report of the second international workshop on human chromosome 5 mapping. Cytogenet. Cell Genet. 1992; 61: 225–231
   PubMedGoogle Scholar
• Le Beau M.M., Westbrook C.A., Diaz M.O., Larson R.A., Rowley J.D., Gasson J.C., Golde D.W., Sherr C.J. Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders. Science 1986; 231: 984–987
   PubMed Web of Science ®Google Scholar
• Le Beau M.M., Epstein N.D., O'Brien S.J., Nienhuis A.W., Yang Y.C., Clark S.C., Rowley J.D. The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q. Proc. Natl. Acad. Sci. USA 1987; 84: 5913–5917
   PubMed Web of Science ®Google Scholar
• Le Beau M.M., Lemons R.S., Espinosa R.B., Larson R.A., Arai N., Rowley J.D. Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Blood 1989; 73: 647–650
   PubMed Web of Science ®Google Scholar
• Goyert S.M., Ferrero E., Rettig W.J., Yenamandra A.K., Obata F., Le Beau M.M. The CD14 monocyte differentiation antigen maps to a region endoding growth factors and receptors. Science 1988; 239: 497–500
   PubMed Web of Science ®Google Scholar
• Huebner K., Isobe M., Croce C.M., Golde D.W., Kaufman S.E., Gasson J.C. The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q-anomaly. Science 1985; 230: 1282–1285
   PubMed Web of Science ®Google Scholar
• Nimer S.D., Golde D.W. The 5q-abnormality. Blood 1987; 70: 1705–1712
   PubMed Web of Science ®Google Scholar
• Kinzler K.W., Nilbert M.C., Vogelstein B., Bryan T.M., Levy D.B., Smith K.J., Preisinger A.C., Hamilton S.R., Hedge P., Markham A., Carlson M., Joslyn G., Groden J., White R., Miki Y., Miyoshi Y., Nishisho I., Nakamura Y. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 1991; 251: 1366–1370
   PubMed Web of Science ®Google Scholar
• Sherr C.J., Rettenmier C.W., Sacca R., Roussel M.F., Look A.T., Stanley E.R. The c-fms Proto-oncogene Product is Related to the Receptor for the Mononuclear Phagocyte Growth Factor, CSF-1. Cell 1985; 41: 665–676
   PubMed Web of Science ®Google Scholar
• Sukhatme V.P., Cao X., Chang L.C., Tsai-Morris C.-H., Stamenkovich D., Ferreira P. C. P., Cohen D.R., Edwards S.A., Shows T.B., Curran T., Le Beau M.M., Adamson E.D. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 1988; 53: 37–43
   PubMed Web of Science ®Google Scholar
• Miyamoto M., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., Miyata T., Taniguchi T. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-b gene regulatory elements. Cell 1988; 54: 903–913
   PubMed Web of Science ®Google Scholar
• Das S.K., Stanley E.R. Structure-function studies of a colony stimulating factor. (CSF-1). J. Biol. Chem. 1982; 275: 13679–13684
   Google Scholar
• Stanley E.R., Guilber L.J., Tushinski R.J., Bartelmez S.H. CSF-1-A mononuclear phagocyte lineage-specific hemopoietic growth factor. J. Cell. Biochem. 1983; 21: 151–159
   PubMed Web of Science ®Google Scholar
• Sherr C.J. Colony-stimulating factor-1 receptor. Blood 1990b; 75: 1–12
   PubMedGoogle Scholar
• Warren M.K., Ralph P. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J. Immunol. 1986; 137: 2281–2285
   PubMed Web of Science ®Google Scholar
• Bartram C.R., Bohlke J.V., Adolph S., Hameister H., Ganser A., Anger B., Heisterkamp N., Groffen J. Deletion of c-fms sequences in the 5q-syndrome. Leukemia 1987; 1: 146–149
   PubMed Web of Science ®Google Scholar
• Nienhuis A.W., Bunn H.F., Turner P.H., Gopal T.V., Nash W.G., O'Brien S.J., Sherr C.J. Expression of the human c-fms proto-oncogene in hematopoietic cells and its deletion in the 5q-syndrome. Cell 1985; 42: 421–428
   PubMed Web of Science ®Google Scholar
• Boultwood J., Rack K., Kelly S., Madden J., Sakaguchi A.Y., Wang L.M., Oscier D.G., Buckle V.J., Wainscoat J.S. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion. Proc. Natl. Acad. Set. USA 1991; 88: 6176–6180
   PubMed Web of Science ®Google Scholar
• Feigner J., Kreipe H., Heidom K., Jaquet K., Zschunke F., Radzun H.-J., Parwaresch M.R. Increased Methylation of the c-fms Protooncogene in Acute Myelomonocytic Leukemias. Pathobiology 1991; 59: 293–298
   PubMed Web of Science ®Google Scholar
• Fujita T., Kimura Y., Miyamoto M., Barsoumian E.L., Taniguichi T. Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1. Nature 1989; 337: 270–272
   PubMed Web of Science ®Google Scholar
• Vilcek J. Peptide Growth Factors and Their Receptors. Handbook of Experimental Pharmacology, M.A. Sporn, A.B. Roberts. Springer-Verlag, New York 1990; 3–38
   Google Scholar
• Harada H., Kitagawa M., Tanaka N., Yamamoto H., Harada K., Ishihara M., Taniguchi T. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and-2. Science 1993; 259: 971–974
   PubMed Web of Science ®Google Scholar
• Nguyen H.Q., Hoffman L.B., Liebermann D.A. The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell 1993; 72: 197–209
   PubMed Web of Science ®Google Scholar
• Neuman W.L., Hallsworth K.A., Le Beau M.M., Westbrook C.A. Molecular analysis of the EGR 1 gene, a candidate tumor suppressor gene in myeloid leukemias. Am. J. Hum. Genet. 1993; 53(suppl.), No. 337
   Google Scholar
• Gilliland D.G., Perrin S., Bunn H.F. Analysis of clonality and EGR-1. Structure/expression in patients with the 5q-syndrome. Leukemia Research 1991; 15(suppl.)21
   Google Scholar
• Reeves B.R., Lobb D.S., Lawler S.D. Identity of the abnormal F-group chromosome associated with polycythemia vera. Human-genetik 1972; 14: 159–161
   Web of Science ®Google Scholar
• Davis M.P., Dewald G.W., Pierre R.V., Hoagland H.C. Hematologic manifestations associated with deletions of the long arm of chromosome 20. Cancer Genet. Cytogenet. 1984; 12: 63–71
   PubMed Web of Science ®Google Scholar
• Testa J.R., Kinnealey A., Rowley J.D., Golde D.W., Potter D. Deletion of the long arm of chromosome 20[del(20)(q11)] in myeloid disorders. Blood 1978; 52: 868–877
   PubMed Web of Science ®Google Scholar
• Roulston D., Espinosa R.B., Stoffel M., Bell G.I., Le Beau M.M. Molecular genetics of myeloid leukemia: identification of the commonly deleted segment of chromosome 20. Blood 1993; 82: 3424–3429
   PubMed Web of Science ®Google Scholar
• Kredich N.M., Hershfield M.S. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. The metabolic basis of inherited disease, C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle. McGraw-Hill, New York, NY 1989; 1045
   Google Scholar
• Asimakopoulos F.A., White N.J., Nacheva E., Green A.R. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and other myeloid malignancies. Br. J. Haematol. 1994; 87(suppl.)118
   Google Scholar
• Morris C.M., Honeybone L.M., Hollings P.E., Fitzgerald P.H. Localization of the SRC oncogene to chromosome band 20q11.2 and loss of this gene with deletion (20q) in two leukemic patients. Blood 1989; 74: 1768–1773
   PubMed Web of Science ®Google Scholar
• Quintrell N., Le Bo R., Varmus H., Bishop J.M., Pettenati M.J., Le Beau M.M., Diaz M.O., Rowley J.D. Identification of a human gene (HCK) that encodes a protein-tyro-sine kinase and is expressed in hemopoietic cells. Mol. Cell Biol. 1987; 7: 2267–2275
   PubMed Web of Science ®Google Scholar
• Ewen M.E., Xing Y., Lawrence J.B., Livingstone D.M. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 1991; 66: 1155–1164
   PubMed Web of Science ®Google Scholar
• Faha B., Ewen M.E., Tsai L.H., Livingston D.M., Harlow E. Interaction between human cyclin A and adenovirus E1 A associated p107 protein. Science 1992; 255: 87–90
   PubMed Web of Science ®Google Scholar